'Towards the clinical evaluation of Galsome-NEO, a glycolipid-adjuvanted mRNA cancer vaccine' - PhD defence

CRIG member Sofie Meulewaeter is defending her doctoral thesis entitled 'Towards the clinical evaluation of Galsome-NEO, a glycolipid-adjuvanted mRNA cancer vaccine'.